Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response
Treatment monitoring is an essential aspect for tuberculosis (TB) disease management. Sputum smear microscopy is the only available tool for monitoring, but it suffers from demerits. Therefore, we sought to evaluate markers and cellular subsets of T regulatory (Treg) cells and T helper (Th) 17 cells...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00157/full |
_version_ | 1811238316698238976 |
---|---|
author | Sonali Agrawal Om Parkash Alangudi Natarajan Palaniappan Ashok Kumar Bhatia Santosh Kumar Devendra Singh Chauhan M. Madhan Kumar |
author_facet | Sonali Agrawal Om Parkash Alangudi Natarajan Palaniappan Ashok Kumar Bhatia Santosh Kumar Devendra Singh Chauhan M. Madhan Kumar |
author_sort | Sonali Agrawal |
collection | DOAJ |
description | Treatment monitoring is an essential aspect for tuberculosis (TB) disease management. Sputum smear microscopy is the only available tool for monitoring, but it suffers from demerits. Therefore, we sought to evaluate markers and cellular subsets of T regulatory (Treg) cells and T helper (Th) 17 cells in pulmonary TB patients (PTB) for TB treatment monitoring. Peripheral blood mononuclear cells (PBMCs) were stimulated in vitro (with purified protein derivative (PPD)) overnight which was followed by a polychromatic flow cytometry approach to study Treg and Th17 markers and cellular subsets in PTB (n = 12) undergoing antituberculous treatment (ATT). The baseline levels of these markers and cellular subsets were evaluated in normal healthy subjects (NHS). We observed a significant decrease in the expression of CD25 (p<0.01) marker and percentage of T-cell subsets like CD4+CD25+ (p<0.001) and CD4+CD25+CD39+ (p<0.05) at the end of intensive phase (IP) as well as in the continuation phase (CP) of ATT. A decrease in CD25 marker expression and percentage of CD4+CD25+ T cell subset showed a positive correlation to sputum conversion both in high and low sputum positive PTB. In eight PTB with cavitary lesions, only CD4+CD25+FoxP3 Treg subset manifested a significant decrease at the end of CP. Thus, results of this study show that CD25 marker and CD4+CD25+ T cells can serve as better markers for monitoring TB treatment efficacy. The Treg subset CD4+CD25+FoxP3 may be useful for prediction of favorable response in PTB with extensive lung lesions. However, these findings have to be evaluated in a larger patient cohort. |
first_indexed | 2024-04-12T12:39:40Z |
format | Article |
id | doaj.art-9768104e18a949448c35a1ae45afe92f |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-04-12T12:39:40Z |
publishDate | 2018-02-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-9768104e18a949448c35a1ae45afe92f2022-12-22T03:32:49ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-02-01910.3389/fimmu.2018.00157308475Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment ResponseSonali Agrawal0Om Parkash1Alangudi Natarajan Palaniappan2Ashok Kumar Bhatia3Santosh Kumar4Devendra Singh Chauhan5M. Madhan Kumar6Department of Immunology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, IndiaDepartment of Immunology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, IndiaDepartment of Clinic, National Institute for Research in Tuberculosis, Chennai, IndiaDepartment of Biotechnology, GLA University, Mathura, IndiaDepartment of Tuberculosis and Chest Diseases, Sarojini Naidu Medical College, Agra, IndiaDepartment of Microbiology and Molecular Biology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, IndiaDepartment of Immunology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, IndiaTreatment monitoring is an essential aspect for tuberculosis (TB) disease management. Sputum smear microscopy is the only available tool for monitoring, but it suffers from demerits. Therefore, we sought to evaluate markers and cellular subsets of T regulatory (Treg) cells and T helper (Th) 17 cells in pulmonary TB patients (PTB) for TB treatment monitoring. Peripheral blood mononuclear cells (PBMCs) were stimulated in vitro (with purified protein derivative (PPD)) overnight which was followed by a polychromatic flow cytometry approach to study Treg and Th17 markers and cellular subsets in PTB (n = 12) undergoing antituberculous treatment (ATT). The baseline levels of these markers and cellular subsets were evaluated in normal healthy subjects (NHS). We observed a significant decrease in the expression of CD25 (p<0.01) marker and percentage of T-cell subsets like CD4+CD25+ (p<0.001) and CD4+CD25+CD39+ (p<0.05) at the end of intensive phase (IP) as well as in the continuation phase (CP) of ATT. A decrease in CD25 marker expression and percentage of CD4+CD25+ T cell subset showed a positive correlation to sputum conversion both in high and low sputum positive PTB. In eight PTB with cavitary lesions, only CD4+CD25+FoxP3 Treg subset manifested a significant decrease at the end of CP. Thus, results of this study show that CD25 marker and CD4+CD25+ T cells can serve as better markers for monitoring TB treatment efficacy. The Treg subset CD4+CD25+FoxP3 may be useful for prediction of favorable response in PTB with extensive lung lesions. However, these findings have to be evaluated in a larger patient cohort.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00157/fulltuberculosisTregTh17treatmentmonitoring |
spellingShingle | Sonali Agrawal Om Parkash Alangudi Natarajan Palaniappan Ashok Kumar Bhatia Santosh Kumar Devendra Singh Chauhan M. Madhan Kumar Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response Frontiers in Immunology tuberculosis Treg Th17 treatment monitoring |
title | Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response |
title_full | Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response |
title_fullStr | Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response |
title_full_unstemmed | Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response |
title_short | Efficacy of T Regulatory Cells, Th17 Cells and the Associated Markers in Monitoring Tuberculosis Treatment Response |
title_sort | efficacy of t regulatory cells th17 cells and the associated markers in monitoring tuberculosis treatment response |
topic | tuberculosis Treg Th17 treatment monitoring |
url | http://journal.frontiersin.org/article/10.3389/fimmu.2018.00157/full |
work_keys_str_mv | AT sonaliagrawal efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT omparkash efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT alangudinatarajanpalaniappan efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT ashokkumarbhatia efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT santoshkumar efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT devendrasinghchauhan efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse AT mmadhankumar efficacyoftregulatorycellsth17cellsandtheassociatedmarkersinmonitoringtuberculosistreatmentresponse |